| Summary: | Blockchain technology provides a major
advance for excipient supply chains, assisting in
the delivery of unadulterated, source, process
and transit verifiable excipients (or APIs and
drug products), but does not alleviate the
necessity for quality audits. The adoption
of blockchain technology should make the
process faster and make the transactional
record more robust and reliable, however other
rate-limiting steps of the excipient supply chain
including transit and testing time will remain. In
terms of pure speed, blockchain is suited to
financial transactions where no physical goods
change hands (such as financial instruments and
derivatives, stocks, insurance, land-registry,
taxation, medical records etc.) but this does not
mean that it should be ignored in respect of the
advantages it could offer in improving the
excipient supply chain.
|
|---|